Search

everythinglearnresearchcommunity

for

Search:↓

Adding licorice gel to laser treatment is more effective for reducing facial hair than laser alone.

A patient's skin eruption was caused by the cancer drug cyclophosphamide and improved after stopping the drug.

Skin structure complexity and variability are crucial for assessing skin toxicity in safety tests.

The document concludes that an experimental drug may help wound healing in Epidermolysis Bullosa, links Hydroa vacciniforme to EBV, discusses diagnosing hair loss disorders, finds many children with eczema have allergies, reviews the safety of a skin medication in children, notes side effects of a Duchenne's treatment, and identifies a marker for pediatric mastocytosis.

Some medications can cause acne, and stopping these drugs is the main treatment.

BRAF inhibitors for melanoma often cause skin side effects, but they can be managed with proper care.

Most hospitalized children with skin issues were boys, with allergic skin diseases like atopic dermatitis being most common, and treatments were usually topical.

Finasteride may be linked to Peyronie’s disease, but more research is needed.

Pemetrexed with cisplatin is safer and more effective than gemcitabine with cisplatin for advanced lung cancer.

PPAR-γ helps control skin oil glands and inflammation, and its disruption can cause hair loss diseases.

Chemotherapy is crucial for treating gynecological cancers but requires careful management due to severe side effects.

Pegvaliase effectively reduces blood phenylalanine levels in most PKU patients, but requires personalized plans and good communication to manage side effects.

Hair transplant is effective for treating hair loss caused by radiation and improves patients' quality of life.

Tebentafusp-tebn improves survival rates in uveal melanoma patients but has common side effects like rash and fatigue.

Bendamustine combined with rituximab is an effective and well-tolerated treatment for certain types of lymphoma.

Taking selenium supplements during chemotherapy may help reduce side effects and improve health markers in ovarian cancer patients.

Scalp cooling can help prevent chemotherapy-induced hair loss with a 50-90% success rate and is safe for patients.

The document provides advice on how to recognize and treat skin-related side effects of cancer drugs known as EGFR inhibitors.

Targeted cancer therapies often cause skin problems that need careful management to improve patient quality of life and treatment success.

EGFR cancer drugs often cause a rash, which can lead to distress and isolation, but may also improve outcomes for some cancer patients. Current treatments for the rash are limited, but a compound called menadione shows promise.

A woman's ovarian tumor causing high testosterone was successfully removed, and her symptoms improved.

Low-dose radiation therapy may improve brain function in some Alzheimer's patients and is generally well-tolerated.

Palliative chemotherapy is cost-effective for advanced gastric and colorectal cancer but not clearly for pancreatic-biliary cancer.

Fulvestrant is a well-tolerated new treatment for advanced breast cancer that may delay chemotherapy.

Giving docetaxel weekly at 40 mg/m² is manageable and has low toxicity for cancer patients.

Targeted cancer therapies have a significant but lower risk of causing hair loss compared to chemotherapy.

Docetaxel and oxaliplatin are effective and have manageable side effects for recurrent platinum-sensitive ovarian cancer.

Liposomal anthracyclines are effective and safer for treating multiple myeloma, especially in elderly patients.

Melanoma development can be linked to the breakdown of skin's melanin-producing units.

Active vitamin D3 might protect hair follicles from radiation damage.